{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T23:25:45Z","timestamp":1772839545021,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40291-018-0327-y","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T05:15:57Z","timestamp":1522818957000},"page":"353-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Study of Triplet-Primed PCR for Identification of CAG Repeat Expansion in the HTT Gene in a Cohort of 503 Indian Cases with Huntington\u2019s Disease Symptoms"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4764-8117","authenticated-orcid":false,"given":"Pratiksha","family":"Chheda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind","family":"Chanekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogita","family":"Salunkhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tavisha","family":"Dama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurita","family":"Pais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Pande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Bendre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilesh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"key":"327_CR1","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1373\/49.10.1726","volume":"49","author":"RL Margolis","year":"2003","unstructured":"Margolis RL, Ross CA. Diagnosis of Huntington disease. Clin Chem. 2003;49:1726\u201332.","journal-title":"Clin Chem"},{"key":"327_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/currents.hd.a3ad1a381ab1eed117675145318c9a80","author":"NS Moily","year":"2014","unstructured":"Moily NS, Kota LN, Anjanappa RM, Venugopal S, Vaidyanathan R, Pal P, et al. Trinucleotide repeats and haplotypes at the huntingtin locus in an Indian sample overlaps with European haplogroup a. PLoS Curr. 2014. https:\/\/doi.org\/10.1371\/currents.hd.a3ad1a381ab1eed117675145318c9a80 .","journal-title":"PLoS Curr"},{"key":"327_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg077946-955F","author":"F Squitieri","year":"2003","unstructured":"Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain. 2003. https:\/\/doi.org\/10.1093\/brain\/awg077946-955F .","journal-title":"Brain"},{"key":"327_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/WCO.0b013e3283632d90","volume":"4","author":"F Govert","year":"2013","unstructured":"Govert F, Schneider SA. Huntington\u2019s disease and Huntington\u2019s disease-like syndromes: an overview. Curr Opin Neurol. 2013;4:420\u20137. https:\/\/doi.org\/10.1097\/WCO.0b013e3283632d90 .","journal-title":"Curr Opin Neurol."},{"key":"327_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ncpneuro0606","volume":"3","author":"SA Schneide","year":"2007","unstructured":"Schneide SA, Walker RH, Bhatia KP. The Huntington\u2019s disease-like syndromes: what to consider in patients with a negative Huntington\u2019s disease gene test. Nat Clin Pract Neurol. 2007;3:517\u201325. https:\/\/doi.org\/10.1038\/ncpneuro0606 .","journal-title":"Nat Clin Pract Neurol"},{"key":"327_CR6","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1038\/gim.2014.146","volume":"16","author":"L Bean","year":"2014","unstructured":"Bean L, Bayrak-Toydemir P. American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease. Genet Med. 2014;16:e2. https:\/\/doi.org\/10.1038\/gim.2014.146 .","journal-title":"Genet Med"},{"key":"327_CR7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1590\/S0004-282X2000000600001","volume":"58","author":"S Raskin","year":"2000","unstructured":"Raskin S, Allan N, Teive HA, Cardoso F, Haddad MS, Levi G, et al. Huntington disease: DNA analysis in Brazilian population. Arq Neuropsiquiatr. 2000;58:977\u201385.","journal-title":"Arq Neuropsiquiatr"},{"key":"327_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0168-9525(01)02625-7","volume":"18","author":"David C Rubinsztein","year":"2002","unstructured":"Rubinsztein David C. Lessons from animal models of Huntington\u2019s disease. Trends Genet. 2002;18:202\u20139.","journal-title":"Trends Genet"},{"key":"327_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/jmg.25.9.589","volume":"25","author":"RM Ridley","year":"1988","unstructured":"Ridley RM, Frith CD, Crow TJ, Conneally PM. Anticipation in Huntington\u2019s disease is inherited through the male line but may originate in the female. J Med Genet. 1988;25:589\u201395.","journal-title":"J Med Genet"},{"key":"327_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/01.GIM.0000106165.74751.15","volume":"6","author":"NT Potter","year":"2004","unstructured":"Potter NT, Spector EB, Prior TW. Technical standards and guidelines for Huntington disease testing. Genet Med. 2004;6:61\u20135.","journal-title":"Genet Med"},{"key":"327_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1089\/gte.2006.10.85","volume":"10","author":"M Falk","year":"2006","unstructured":"Falk M, Vojtis Kova M, Lukas Z, Kroupova I, Froster U. Simple procedure for automatic detection of unstable alleles in the myotonic dystrophy and Huntington\u2019s disease loci. Genetic Testing. 2006;10:85\u201397.","journal-title":"Genetic Testing"},{"key":"327_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1159\/000444714","volume":"16","author":"M Zhao","year":"2016","unstructured":"Zhao M, Lee CG, Hai-Yang Law HY, Chong SS. Enhanced detection and sizing of the HTT CAG repeat expansion in Huntington disease using an improved triplet-primed PCR assay. Neurodegener Dis. 2016;16:348\u201351. https:\/\/doi.org\/10.1159\/000444714 .","journal-title":"Neurodegener Dis"},{"key":"327_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12033-010-9260-y","volume":"45","author":"T Todorov","year":"2010","unstructured":"Todorov T, Todorova A, Georgieva B, Mitev V. A unified rapid PCR method for detection of normal and expanded trinucleotide alleles of CAG repeats in Huntington chorea and CGG repeats in fragile X syndrome. Mol Biotechnol. 2010;45:150\u20134.","journal-title":"Mol Biotechnol"},{"key":"327_CR14","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1093\/clinchem\/43.12.2422","volume":"43","author":"T Toth","year":"1997","unstructured":"Toth T, Findlay I, Nagy B, Papp Z. Accurate sizing of (CAG)n repeats causing Huntington disease by fluorescent PCR. Clin Chem. 1997;43:2422\u20133.","journal-title":"Clin Chem"},{"key":"327_CR15","volume-title":"Huntington\u2019s disease","author":"G Bates","year":"2014","unstructured":"Bates G, Tabrizi S, Jones L. Huntington\u2019s disease. 4th ed. Oxford: Oxford University Press; 2014.","edition":"4"},{"key":"327_CR16","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1373\/clinchem.2007.096503","volume":"54","author":"CR Teo","year":"2008","unstructured":"Teo CR, Wang W, Law HY, Lee CG, Chong SS. Single-step scalable-throughput molecular screening for Huntington disease. Clin Chem. 2008;54:964\u201372.","journal-title":"Clin Chem"},{"key":"327_CR17","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1073\/pnas.0308679101","volume":"101","author":"NS Wexler","year":"2004","unstructured":"Wexler NS, Lorimer J, Porter J, Gomez F, Moskowitz C, Shackell E, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington\u2019s disease age of onset. Proc Natl Acad Sci. 2004;101:3498\u2013503.","journal-title":"Proc Natl Acad Sci"},{"key":"327_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1399-0004.2006.00668.x","volume":"70","author":"A Semaka","year":"2006","unstructured":"Semaka A, Creighton S, Warby S, Hayden MR. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet. 2006;70:283\u201394.","journal-title":"Clin Genet"},{"key":"327_CR19","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/ejhg.2012.200","volume":"21","author":"M Losekoot","year":"2013","unstructured":"Losekoot M, van Belzen MJ, Seneca S, Bauer P, Stenhouse SA, Barton DE. European Molecular Genetic Quality Network (EMQN). EMQN\/CMGS best practice guidelines for the molecular genetic testing of Huntington disease. Eur J Hum Genet. 2013;21:480\u20136. https:\/\/doi.org\/10.1038\/ejhg.2012.200 .","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"327_CR20","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1136\/jmg.2006.045120","volume":"44","author":"OW Quarrell","year":"2007","unstructured":"Quarrell OW, Rigby AS, Barron L, Crow Y, Dalton A. Reduced penetrance alleles for Huntington\u2019s disease: a multi-centre direct observational study. J Med Genet. 2007;44(3):e68.","journal-title":"J Med Genet."},{"key":"327_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1212\/WNL.0000000000002858","volume":"87","author":"C Kay","year":"2016","unstructured":"Kay C, Collins JA, Miedzybrodzka Z, Madore SJ, Gordon ES, Gerry N, et al. Huntington disease reduced penetrance alleles occur at high frequency in the general population. Neurology. 2016;87:282\u20138. https:\/\/doi.org\/10.1212\/WNL.0000000000002858 Epub 2016 Jun 22.","journal-title":"Neurology."},{"key":"327_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1399-0004.2010.01388.x","volume":"78","author":"J Sequeiros","year":"2010","unstructured":"Sequeiros J, Ramos EM, Cerqueira J, Costa MC, Sousa A, Pinto-Basto J, Alonso I, et al. Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clin Genet. 2010;78:381\u20137. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01388.x .","journal-title":"Clin Genet."},{"key":"327_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4172\/2161-1041.1000141","volume":"4","author":"J Sheth","year":"2015","unstructured":"Sheth J, Shah S, Patel H, Bhavsar R, Bhatt K, Sheth F. A study on triplet repeat expansion disorders in Western Indian population. Hereditary Genet. 2015;4:141. https:\/\/doi.org\/10.4172\/2161-1041.1000141 .","journal-title":"Hereditary Genet"},{"key":"327_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/sj.ejhg.5200515","volume":"8","author":"S Pramanik","year":"2000","unstructured":"Pramanik S, Basu P, Gangopadhaya PK, Sinha KK, Jha DK, Sinha S, et al. Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India. Eur J Hum Genet. 2000;8:678\u201382.","journal-title":"Eur J Hum Genet."},{"key":"327_CR25","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1002\/mds.25237","volume":"27","author":"LJ Cloud","year":"2012","unstructured":"Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA. Seizures in juvenile Huntington\u2019s disease: frequency and characterization in a multicenter cohort. Mov Disord. 2012;27:1797\u2013800. https:\/\/doi.org\/10.1002\/mds.25237 (Epub 2012 Nov 2).","journal-title":"Mov Disord."},{"key":"327_CR26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jmoldx.2012.09.005","volume":"15","author":"M Jama","year":"2013","unstructured":"Jama M, Millson A, Miller CE, Lyon E. Triplet repeat primed PCR simplifies testing for Huntington disease. J Mol Diagn. 2013;15:255\u201362.","journal-title":"J Mol Diagn"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-018-0327-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-018-0327-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-018-0327-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:44:24Z","timestamp":1604105064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-018-0327-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1007\/s40291-018-0327-y","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]},"assertion":[{"value":"4 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All the authors were employed by Metropolis Healthcare Ltd. PC, MC, YS, TD, AP, SP, RB and NS have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No funding supported this\u00a0study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The study procedures were approved by Conscience Independent Ethics Committee (CIEC). Informed consent was obtained from all participating individuals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}